Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2013 | 09-2012 | 09-2011 | 09-2010 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128 | 1 | 22 | 9 | N/A |
| Receivables | 11 | N/A | N/A | N/A | N/A |
| TOTAL | $138 | $1 | $22 | $9 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 324 | 281 | 0 | N/A | N/A |
| TOTAL | $324 | $281 | $0 | $0 | $0 |
| Total Assets | $463 | $283 | $22 | $9 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 114 | 358 | 32 | 2 | 0 |
| TOTAL | $121 | $358 | $32 | $2 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 96 | 31 | 0 | 0 | 0 |
| TOTAL | $96 | $31 | $N/A | $N/A | $N/A |
| Total Liabilities | $217 | $389 | $32 | $2 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,864 | 6,796 | 12,000 | N/A | N/A |
| Common Shares | 1 | 1 | 0 | 1 | N/A |
| Retained earnings | -2,112 | -1,166 | -56 | -2 | N/A |
| TOTAL | $245 | $-106 | $-10 | $7 | $N/A |
| Total Liabilities And Equity | $463 | $283 | $22 | $9 | $0 |